Company profile for Leyden Labs

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Leyden Labs’ proactive approach protects against a broad range of viruses To protect from what comes next, we need to act proactively and be ready for a broad range of viruses. At Leyden Labs, we enable this by developing our platform and products with three innovative concepts. The city of Leiden (The Netherlands) inspired our name. For centuries, Leiden is known for unconventional thinking, the freedom to express this op...
Leyden Labs’ proactive approach protects against a broad range of viruses To protect from what comes next, we need to act proactively and be ready for a broad range of viruses. At Leyden Labs, we enable this by developing our platform and products with three innovative concepts. The city of Leiden (The Netherlands) inspired our name. For centuries, Leiden is known for unconventional thinking, the freedom to express this openly and scientific breakthroughs such as the first publications of Galileo’s famous Discorsi. At Leyden Labs, we want to free humanity from the burden of respiratory viruses to let people live life to the fullest.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Netherlands
Address
Address
Keizersgracht 290 A 1016 EW Amsterdam
Telephone
Telephone
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20251001741614/en/Leyden-Labs-Secures-%E2%82%AC30-million-from-European-Innovation-Council-Fund-and-Invest-NL-to-Advance-Nasal-Spray-Against-Respiratory-Viruses

BUSINESSWIRE
02 Oct 2025

https://www.businesswire.com/news/home/20250603017541/en/Leyden-Labs-Lands-%E2%82%AC20-Million-EIB-Investment-Facilitated-by-HERA-to-Advance-Pandemic-Preparedness-Activities

BUSINESSWIRE
03 Jun 2025

https://www.businesswire.com/news/home/20250408557307/en/Leyden-Labs-Publishes-New-Data-Confirming-Potential-of-Intranasal-Antibody-Approach

BUSINESSWIRE
08 Apr 2025

https://www.businesswire.com/news/home/20240912791207/en

BUSINESSWIRE
12 Sep 2024

https://www.globenewswire.com/news-release/2022/01/18/2368252/0/en/Leyden-Labs-Licenses-Pan-Influenza-Antibody-from-Janssen.html

GLOBENEWSWIRE
18 Jan 2022

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty